RPG Life Sciences Ltd
Mon 2/02/2026,15:58:32 | NSE : RPGLIFE
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 1981.00
Previous Close
₹ 1981.40
Volume
9505
Mkt Cap ( Rs. Cr)
₹3272.91
High
₹ 2050.00
Low
₹ 1967.00
52 Week High
₹ 2725.00
52 Week Low
₹ 1835.00
Book Value Per Share
₹ 334.94
Dividend Yield
1.20
Face Value
₹ 8.00
What’s Your Call?
Collective community sentiment on RPG Life Sciences Ltd
Your Vote -
Buy
55.56%
Hold
11.11%
Sell
33.33%
55.56%
9 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts RPG Life Sciences Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
RPG Life Sciences - General Updates
-
RPG Life Sciences - General Updates
-
RPG Life Sciences - Copy of Newspaper Publication
-
RPG Life Sciences - General Updates
-
RPG Life Sciences - Announcement under Regulation 30 (LODR)-Investor Presentation
-
RPG Life Sciences - General Updates
-
RPG Life Sciences - Announcement under Regulation 30 (LODR)-Investor Presentation
-
RPG Life Sciences - Press Release
-
RPG Life Sciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release
-
RPG Life Sciences - Outcome of Board Meeting
-
RPG Life Sciences Q3 net profit down 36.64% at Rs 22.13 cr
-
RPG Life Sciences - Board Meeting Outcome for Outcome Of The Board Meeting Held On January 27, 2026.
-
RPG Life Sciences - Outcome of Board Meeting
-
RPG Life Sciences has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025
-
RPG Life Sciences - Board Meeting Intimation for Intimation Of Board Meeting
-
RPG Life Sciences - Certificate under SEBI (Depositories and Participants) Regulations, 2018
-
RPG Life Sciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
-
RPG Life Sciences - Copy of Newspaper Publication
-
RPG Life Sciences - General Updates
-
RPG Life Sciences - Disclosure Under Regulation 30 Of SEBI LODR, 2015 For Details Of Order Received From GST Authority, Mahar
-
RPG Life Sciences - Updates
-
RPG Life Sciences - Incorporation Of A Wholly Owned Subsidiary.
-
RPG Life Sciences - Trading Window
-
RPG Life Sciences - Disclosure Under Regulation 30(5)
-
RPG Life Sciences - Intimation With Respect To Proposed Incorporation Of A Wholly Owned Subsidiary Is Enclosed Herewith
-
RPG Life Sciences - Announcement under Regulation 30 (LODR)-Change in Management
-
RPG Life Sciences - Outcome Of The Board Meeting Held On December 15, 2025
-
RPG Life Sciences - General Updates
-
RPG Life Sciences - Disclosure Under Regulation 30 Of SEBI LODR, 2015 For Details Of Order Received From GST Authority, Gujar
-
RPG Life Sciences - Copy of Newspaper Publication
Key fundamentals
Evaluate the intrinsic value of RPG Life Sciences Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 530.53 | 374.85 | 307.61 | 256.06 | 217.71 |
| Liabilities | 530.53 | 374.85 | 307.61 | 256.06 | 217.71 |
| Equity | 13.23 | 13.23 | 13.23 | 13.23 | 13.23 |
| Gross Profit | 159.65 | 128.15 | 102.69 | 86.36 | 69.93 |
| Net Profit | 183.24 | 87.66 | 67.64 | 51.48 | 40 |
| Cash From Operating Activities | 77.86 | 94.36 | 90.82 | 64.75 | 58.27 |
| NPM(%) | 28.04 | 15.06 | 13.19 | 11.69 | 10.27 |
| Revenue | 653.43 | 582.05 | 512.81 | 440.16 | 389.14 |
| Expenses | 493.78 | 453.9 | 410.12 | 353.8 | 319.21 |
| ROE(%) | 33.07 | 15.82 | 12.21 | 9.29 | 7.22 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|---|---|---|---|
| 27 Jun 2025 | 4 | 50 | 1.21 | 2091.3 |
| 27 Jun 2025 | 20 | 250 | 1.21 | 2174.5 |
| 28 Jun 2024 | 16 | 200 | 1.21 | 1546.4 |
| 14 Jul 2022 | 9.6 | 120 | 1.21 | 590.65 |
| 13 Aug 2021 | 7.2 | 90 | 1.21 | 485.1 |
| 24 Mar 2020 | 4 | 50 | 1.21 | 219.05 |
| 22 Jul 2019 | 2.4 | 30 | 1.21 | 234.7 |
| 19 Jul 2018 | 2.4 | 30 | 1.21 | 412.1 |
| 13 Jul 2017 | 2.8 | 35 | 1.21 | 440.15 |
| 22 Mar 2016 | 1.6 | 20 | 1.21 | 252.3 |
| 20 Jul 2015 | 0.8 | 10 | 1.21 | 140.15 |
| 11 Sep 2014 | 1.2 | 15 | 1.21 | 70.6 |
| 11 Jul 2013 | 1.2 | 15 | 1.21 | 61.55 |
| 24 Jul 2012 | 0.8 | 10 | 1.21 | 64 |
| 14 Jul 2011 | 1.6 | 20 | 1.21 | 80 |
| 15 Jul 2010 | 1.44 | 18 | 1.21 | 70.65 |
| 30 Jul 2009 | 1.2 | 15 | 1.21 | 31.35 |
| 11 Aug 2008 | 1.2 | 15 | 1.21 | 25.75 |
Peers
Other companies within the same industry or sector that are comparable to RPG Life Sciences Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 683.60 | -1.06 | 0.00 | 1132.59 | 301.39 | 0.73 |
| Lotus Eye Hospital and Institute Ltd | 122.09 | -5.00 | 381.53 | 4127.03 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 7.95 | -1.00 | 0.00 | 25890.21 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 585.80 | 2.86 | 0.00 | 3891.88 | -604.77 | 0.00 |
Company Info
2009 - Rpg Life Sciences Limited has informed that Mr. Ankur Kumar has been appointed as Controller - Legal & Company Secretary and Compliance Officer of the Company with effect from January 08, 2009. 2010 - Mr. Ajit Singh Chouhan, presently a Director of the Company has been appointed as Managing Director of the Company. - Mr. Sachin Raole, General Manager Finance has been designated as Chief Financial Officer (CFO) of the Company. 2011 - RPG Life Sciences launches dialysis deferring drug. - Mr. Rajesh Shirambekar has been appointed as Head - Legal & Company Secretary and Compliance Officer of the Company. 2012 -Board has recommended an equity dividend of Rs. 0.80 per share (10%). 2013 -RPG Life Sciences Ltd received 'EUGMP certification' for its Navi Mumbai API facility." -RPG Life Sciences bagged "Asia's Best Employer Brand Awards 2013" in Singapore. 2014 -Board has recommended a total dividend of Rs. 2.00 per share (25%) for the year 2014. 2015 -RPG Life Plans Skincare Foray 2016 -RPG Life Sciences - RPG Life Sciences announces foray into Cosmetic Industry -RPG Life gains over 14 pct on getting EUGMP certification -RPG Life Sciences - RPG Life Sciences to expand its formulations business 2019 -RPG Life Sciences enters Anti-Diabetic therapeutic area.
2009 - Rpg Life Sciences Limited has informed that Mr. Ankur Kumar has been appointed as Controller - Legal & Company Secretary and Compliance Officer of the Company with effect from January 08, 2009. 2010 - Mr. Ajit Singh Chouhan, presently a Director of the Company has been appointed as Managing Director of the Company. - Mr. Sachin Raole, General Manager Finance has been designated as Chief Financial Officer (CFO) of the Company. 2011 - RPG Life Sciences launches dialysis deferring drug. - Mr. Rajesh Shirambekar has been appointed as Head - Legal & Company Secretary and Compliance Officer of the Company. 2012 -Board has recommended an equity dividend of Rs. 0.80 per share (10%). 2013 -RPG Life Sciences Ltd received 'EUGMP certification' for its Navi Mumbai API facility." -RPG Life Sciences bagged "Asia's Best Employer Brand Awards 2013" in Singapore. 2014 -Board has recommended a total dividend of Rs. 2.00 per share (25%) for the year 2014. 2015 -RPG Life Plans Skincare Foray 2016 -RPG Life Sciences - RPG Life Sciences announces foray into Cosmetic Industry -RPG Life gains over 14 pct on getting EUGMP certification -RPG Life Sciences - RPG Life Sciences to expand its formulations business 2019 -RPG Life Sciences enters Anti-Diabetic therapeutic area.
Read More
Parent Organisation
RPG Life Sciences Ltd.
Founded
29/03/2007
Managing Director
Mr.Ashok Nair
NSE Symbol
RPGLIFEEQ
FAQ
The current price of RPG Life Sciences Ltd is ₹ 1978.90.
The 52-week high for RPG Life Sciences Ltd is ₹ 2050.00 and the 52-week low is ₹ 1967.00.
The market capitalization of RPG Life Sciences Ltd is currently ₹ 3272.91. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy RPG Life Sciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in RPG Life Sciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase RPG Life Sciences Ltd shares.
The CEO of RPG Life Sciences Ltd is Mr.Ashok Nair, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
